Molecular biomarkers in drug development
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (22) , 976-983
- https://doi.org/10.1016/s1359-6446(04)03272-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Characteristic Expression Profiles Induced by Genotoxic Carcinogens in Rat LiverToxicological Sciences, 2004
- Clinical biomarkers in drug discovery and developmentNature Reviews Drug Discovery, 2003
- Prognostic significance of tumor oxygenation in humansCancer Letters, 2003
- Application of toxicogenomics to drug developmentExpert Review of Molecular Diagnostics, 2002
- The impact of pharmacogenetics and pharmacogenomics on drug discoveryNature Reviews Drug Discovery, 2002
- Toxicogenomics and drug discovery: will new technologies help us produce better drugs?Nature Reviews Drug Discovery, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- An approach to the validation of markers for use in AIDS clinical trials.Clinical Infectious Diseases, 1997
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997